Dr. Eric Berg DC · 2026-07-10 · Eric Berg (host), Steve, Dominic
The Dr. Berg Show LIVE - July 10, 2026
46 research-tied claims examined: 6 contradicted 5 overstated 8 context 25 supported 2 unverified
6 Contradicted by research
Between meals, a peristaltic cleansing wave moves through the colon, and eating stops this wave.
"between meals you have a wave of—it's called peristalsis that actually cleans your colon when you're not eating. And so as soon as you eat, that stops." (said at 0:19:40)
The speaker misattributes the interdigestive migrating motor complex (MMC)—often called the "housekeeper" wave of the gut—to the colon. The MMC is a cyclic motor pattern that occurs during fasting and cleanses the stomach and small intestine (duodenum, jejunum, and ileum), not the colon. While feeding does disrupt the MMC pattern in the upper gastrointestinal tract, the wave itself operates in the stomach and small intestine, not the large intestine (colon).
Normal stomach acidity has a pH between 1.5 and 3.0, and elevated stomach pH causes the lower esophageal sphincter valve to fail to close properly.
"Normally we have a stomach between 1.5 and 3 pH, which is extremely acidic. And as that pH goes higher, becomes more alkaline, the valve doesn't close as much." (said at 0:22:15)
While normal fasting gastric juice is highly acidic with a typical pH between 1.5 and 3.0, the claim that elevated (more alkaline) gastric pH causes the lower esophageal sphincter (LES) to fail to close properly is contradicted by clinical evidence and established gastrointestinal physiology. In human physiological studies, changes in luminal acidity do not determine baseline LES closure or resting pressure. Comprehensive reviews of gastroesophageal reflux disease (GERD) pathophysiology demonstrate that LES dysfunction is driven by transient lower esophageal sphincter relaxations (TLESRs), intrinsic myogenic hypotensive resting tone, anatomical disruption (such as hiatal hernia), and delayed gastric emptying with gastric distension, rather than hypochlorhydria or elevated stomach pH.
- contradicts: Pathophysiology of gastro-oesophageal reflux disease. (Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 2006) · cited 98x in the literature
"The pathogenesis of gastro-oesophageal reflux disease is multifactorial, involving transient lower oesophageal sphincter relaxations and other lower oesophageal sphincter pressure abnormalities." (abstract, results, passage verified)
pubmed - contradicts: Oesophageal acidification does not increase lower oesophageal sphincter pressure. (Gut 1990) · cited 3x in the literature
"In normal human subjects, distal oesophageal acidification did not elicit a change in LOS pressure... We conclude that contrary to common belief, distal oesophageal acidification itself does not affect LOS pressure in man or the cat." (abstract, results)
pubmedfull study (doi) - contradicts: Overview of pathophysiological features of GERD. (Minerva gastroenterologica e dietologica 2017) · cited 18x in the literature
"Several mechanisms have been proposed: decreased salivation, decreased lower esophageal sphincter pressure resting tone, presence of hiatal hernia, increased number of transient lower esophageal sphincter relaxations, increased acid, and pepsin secretion, duodeno-gastro-esophageal reflux of bile acids and trypsin." (abstract, results, passage verified)
pubmedfull study (doi)
Scientific data demonstrates that testosterone supports the prostate and can lower the risk of prostate cancer.
"In fact, there's even data to show that testosterone can help really support the prostate in many different ways and even lower the risk for cancer of the prostate. I just stumbled on that data" (said at 0:38:25)
Randomized controlled trials and systematic reviews do not support the claim that testosterone therapy lowers the risk of prostate cancer. Large meta-analyses and randomized trials (including the TRAVERSE trial) demonstrate that testosterone replacement therapy in hypogonadal men is safe and does not increase the incidence of prostate cancer compared to placebo, but it also does not reduce prostate cancer risk. Similarly, prospective cohort studies show that endogenous testosterone levels are not associated with reduced prostate cancer risk (relative risk ~0.99).
- contradicts: Endogenous and exogenous testosterone and the risk of prostate cancer and increased prosta… (BJU international 2016) · cited 135x in the literature
"Twenty estimates were included in a meta-analysis, which produced a summary relative risk (SRR) of prostate cancer for an increase of 5 nmol/L of testosterone of 0.99 (95% confidence interval [CI] 0.96, 1.02) without heterogeneity (I² = 0%). ... Prostate cancer appears to be unrelated to endogenous testosterone levels. TRT for symptomatic hypogonadism does not appear to increase PSA levels nor the risk of prostate cancer development." (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - contradicts: Prostate Risk and Monitoring During Testosterone Replacement Therapy. (The Journal of clinical endocrinology and metabolism 2024) · cited 14x in the literature
"Among men with hypogonadism, carefully screened to exclude those at high risk of prostate cancer, the incidences of high-grade or any prostate cancer, acute urinary retention, surgical procedure for benign prostatic hyperplasia, prostate biopsy, or new pharmacologic therapy for lower urinary tract symptoms were low and did not differ between the testosterone and placebo groups." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Cardiovascular and prostate cancer risk associated to testosterone replacement therapy - a… (International journal of impotence research 2026) · cited 3x in the literature
"TTh was not associated with a statistically significant increase in MACE (OR 0.83; 95% CI: 0.52-1.32; I² = 53.2%), PCaE (OR 0.88; 95% CI: 0.52-1.51; I² = 0.0%), or CsPcE (OR 1.13; 95% CI: 0.39-3.26; I² = 0.0%)." (abstract, results, passage verified)
pubmedfull study (doi)
Alcohol consumption is a primary dietary factor fueling male breast cancer in genetically susceptible individuals.
"if uh and men are actually having breast cancer, um usually that stems from a genetic thing. There is a genetic factor, and the big thing that really fuels that problem is alcohol. Uh so that's one thing. If you have that genetic that puts you at risk for breast cancer, that's one thing you want to avoid, alcohol." (said at 0:39:38)
The claim that alcohol is the primary factor driving male breast cancer in genetically susceptible men is contradicted by large-scale epidemiological evidence. In the largest investigation to date from the Male Breast Cancer Pooling Project consortium (2,378 cases and 51,959 controls across 20 cohort and case-control studies), neither recent alcohol intake nor average daily alcohol consumption showed a significant association with male breast cancer risk overall. While alcohol is an established risk factor for female breast cancer and genetic mutations (such as BRCA2) substantially elevate male breast cancer risk, there is no robust evidence that alcohol intake is a primary driver or major modifier of male breast cancer in genetically susceptible individuals.
Eye twitching is a classic clinical indicator of magnesium deficiency.
"Eye twitching is a classic clue that you are low in magnesium. So, start to increase more and more magnesium glycinate until that completely goes away." (said at 0:50:25)
Eyelid twitching (eyelid myokymia) is a common, benign condition most frequently triggered by stress, fatigue, digital screen time, and high caffeine intake, rather than magnesium deficiency. In a case-control study evaluating 103 patients presenting with eyelid twitching lasting more than two weeks compared to 103 healthy controls, researchers found no significant differences in blood electrolyte levels, including magnesium, between the groups. There is no high-quality clinical trial evidence establishing magnesium deficiency as a primary cause of isolated eyelid twitching or supporting magnesium titration as a standard treatment.
Cysts are a mechanism by which the body encapsulates toxic substances.
"And cysts are a way your body is trying to encapsulate something toxic." (said at 1:03:22)
In medical pathology, cysts are closed sac-like structures lined by epithelium or endothelium containing fluid, gaseous, or semi-solid material. Cysts arise from distinct pathological and physiological processes, including genetic mutations (e.g., PKD1/PKD2 mutations driving fluid secretion and epithelial proliferation in polycystic kidney disease), glandular or ductal obstruction (such as epidermoid or retention cysts), hormonal dysregulation (such as ovarian follicular cysts), developmental defects, or specific parasitic infections. They are not an adaptive physiological mechanism designed to sequester or encapsulate systemic "toxic substances." When the body isolates persistent foreign bodies or pathogens, it utilizes granulomatous inflammation or fibrous walling-off (abscess formation), not epithelial cystogenesis.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.